With this acquisition, MYRUNS becomes a majority partner of Evolgene Genomics, with the aim of also advancing in the treatment of biomass, the development of high-added-value biomaterials, and the development of next-generation biofuels for clean energy production."Evolgene Genomics has already a portfolio of ancestral enzymes and various companies have expressed interest in the technology" says Garcia-Roldan.